Gary Zweiger

Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018.

Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018.

Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018.

Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018.

Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland.

Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland.

Cota Capital Management LLC (Cota Capital) is a venture capital firm founded in 2014 by Babak Poushanchi and Bobby Yazdani. The firm is headquartered in San Francisco, California.

Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland.